Lv3
290 积分 2025-08-24 加入
Targeting LKB1/STK11-mutant cancer: distinct metabolism, microenvironment, and therapeutic resistance
2小时前
已完结
Concomitant genomic features stratify prognosis to patients with advanced EGFR mutant lung cancer
2天前
已完结
Improved survival and intracranial tumor control of EGFR-mutated NSCLC patients with newly developed brain metastases following stereotactic radiosurgery and EGFR-TKI: a large retrospective cohort study and meta-analyses
3天前
已完结
Safety of Readministration of EGFR-TKI After Onset of Interstitial Lung Disease in Advanced EGFR-Mutated NSCLC: A Systematic Review and Meta-Analysis
3天前
已完结
Efficacy and safety of immune checkpoint inhibitors for individuals with advanced EGFR-mutated non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitors: a systematic review, meta-analysis, and network meta-analysis
3天前
已完结
First-line concomitant EGFR-TKI + chemotherapy versus EGFR-TKI alone for advanced EGFR -mutated NSCLC: a meta-analysis of randomized phase III trials
3天前
已完结
Feasibility and safety of EGFR-TKI neoadjuvant therapy for EGFR-mutated NSCLC: A meta-analysis
3天前
已完结
Efficacy and safety of EGFR-TKI combined with early brain radiotherapy versus TKI alone in patients with EGFR-mutated NSCLC with brain metastases: a systematic review and meta-analysis
3天前
已完结
Chemotherapy-Based Combination Regimens for Advanced EGFR-Mutant NSCLC After EGFR-TKI Failure: A Network Meta-Analysis
3天前
已完结
Impact of ABCG2 rs2231142(421C>A) Variant on the Clinical Outcomes of Patients WithEGFR-mutated Non-small Cell Lung Cancer Treated With Gefitinib: A Comprehensive Meta-analysis
3天前
已完结
皖公网安备34019202002308
